Well Told Grants

Federal grant programs / Allergy and Infectious Diseases Research

Allergy and Infectious Diseases Research in Mississippi

Allergy and Infectious Diseases Research (93.855) awarded $7.5 million to recipients in Mississippi in 17 grants from fiscal 2021 to 2025, less than 0.1% of the program's national total. The University of Southern Mississippi received the most, $3.7 million.

By year

Grants under this program to recipients in Mississippi
Fiscal yearAwardsAmount
FY 20215$1.1 million
FY 20227$2.0 million
FY 20233$543,280
FY 20245$1.5 million
FY 20257$2.4 million

Recipients in Mississippi

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
The University of Southern MississippiColleges and universities9$3.7 million
Mississippi State UniversityColleges and universities4$1.7 million
University of Mississippi Medical CenterColleges and universities3$1.7 million
Jackson State UniversityColleges and universities1$553,487

Counted by the recipient's location. A recipient based in Mississippi may carry out the work elsewhere.

Open opportunities under this program

See all 93 on the program page

Questions people ask

How much Allergy and Infectious Diseases Research money goes to Mississippi?

$7.5 million from fiscal 2021 to 2025, across 17 awards. Mississippi ranks 46th of 52 states and territories for this program.

Who receives Allergy and Infectious Diseases Research money in Mississippi?

The largest recipient is The University of Southern Mississippi, with $3.7 million in 9 awards. Next are Mississippi State University and University of Mississippi Medical Center.

Can organizations in Mississippi apply now?

Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Allergy and Infectious Diseases Research in other states

Other large programs in Mississippi

All federal grants in Mississippi

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.